Product Code: ETC073520 | Publication Date: Jun 2021 | Updated Date: Jun 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The United States Organ Preservation Market is a vital segment of the healthcare industry focused on maintaining organs outside of the body before transplantation. With the increasing demand for organ transplants and advancements in medical technology, the market is experiencing significant growth. Key players in the US organ preservation market include Organ Recovery Systems, XVIVO Perfusion, and TransMedics. Various preservation methods such as hypothermic machine perfusion and normothermic machine perfusion are being increasingly adopted to improve organ quality and increase transplant success rates. The market is driven by factors such as the rising prevalence of chronic diseases leading to organ failure, growing organ transplant procedures, and the expanding research and development activities in the field of organ preservation. Continuous innovations, collaborations between research institutions and industry players, and government initiatives supporting organ donation are expected to further propel the growth of the US organ preservation market.
The United States Organ Preservation Market is experiencing a shift towards the adoption of advanced technologies such as hypothermic machine perfusion and normothermic machine perfusion to improve the quality and viability of donor organs. These technologies allow for better preservation of organs during transportation and storage, increasing the chances of successful organ transplants. Additionally, there is a growing focus on the development of organ preservation solutions that address specific organ types, such as hearts, livers, and kidneys, to cater to the increasing demand for transplantable organs. The market is also witnessing collaborations between healthcare organizations, research institutions, and technology companies to drive innovation in organ preservation techniques. Overall, the US Organ Preservation Market is moving towards more personalized and efficient solutions to meet the growing demand for organ transplants.
The United States Organ Preservation Market faces several challenges, including the limited availability of donor organs, leading to high demand and potential supply shortages. The transportation and logistics involved in preserving and transporting organs to recipients can also be complex and costly, impacting the overall efficiency of the market. Additionally, the lack of standardized protocols and regulations for organ preservation techniques can pose challenges in ensuring the quality and viability of preserved organs. Furthermore, the high cost associated with organ preservation technologies and procedures can present financial barriers for healthcare institutions and patients. These challenges highlight the need for continued research and innovation in organ preservation technologies, as well as improved coordination among healthcare providers, policymakers, and regulatory bodies to address the issues faced by the US Organ Preservation Market.
The United States Organ Preservation Market presents promising investment opportunities in technologies aimed at improving organ preservation methods for transplantation. Advancements in organ preservation solutions, such as hypothermic and normothermic perfusion systems, are gaining traction due to their potential to extend the viability of donor organs and reduce the risk of organ rejection post-transplantation. Additionally, the growing prevalence of end-stage organ failure and the increasing number of organ transplant procedures in the US create a demand for innovative organ preservation solutions. Investors may consider opportunities in companies developing cutting-edge organ preservation technologies, as well as those involved in research and development collaborations with healthcare institutions and organ procurement organizations to address the unmet needs in the field.
The US government has various policies that impact the Organ Preservation Market, primarily overseen by the Food and Drug Administration (FDA) and the United Network for Organ Sharing (UNOS). The FDA regulates organ preservation solutions and devices to ensure their safety and efficacy. UNOS manages the national organ transplant system, allocating organs to patients based on established criteria. Additionally, government funding for research and development in organ preservation technologies plays a significant role in advancing the field. Policies related to reimbursement for organ preservation procedures through Medicare and private insurance also influence market dynamics. Overall, these regulations and initiatives aim to improve patient outcomes, increase access to organ transplants, and drive innovation in organ preservation methods.
The future outlook for the United States Organ Preservation Market is promising, driven by increasing research and development activities in the field of organ transplantation, rising prevalence of chronic diseases necessitating organ transplants, and advancements in organ preservation techniques. The market is expected to witness significant growth due to the growing number of organ transplant procedures being performed and the expanding donor pool. Additionally, the adoption of innovative technologies such as hypothermic machine perfusion and normothermic machine perfusion is expected to drive market growth further. Government initiatives to promote organ donation and transplantation are also likely to contribute to the market`s expansion. Overall, the US Organ Preservation Market is poised for substantial growth in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Organ Preservation Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Organ Preservation Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Organ Preservation Market - Industry Life Cycle |
3.4 United States (US) Organ Preservation Market - Porter's Five Forces |
3.5 United States (US) Organ Preservation Market Revenues & Volume Share, By Solution, 2021 & 2031F |
3.6 United States (US) Organ Preservation Market Revenues & Volume Share, By Organ Type, 2021 & 2031F |
3.7 United States (US) Organ Preservation Market Revenues & Volume Share, By Preservation Technology, 2021 & 2031F |
4 United States (US) Organ Preservation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United States (US) Organ Preservation Market Trends |
6 United States (US) Organ Preservation Market, By Types |
6.1 United States (US) Organ Preservation Market, By Solution |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Organ Preservation Market Revenues & Volume, By Solution, 2018 - 2027F |
6.1.3 United States (US) Organ Preservation Market Revenues & Volume, By University of Wisconsin (UW), 2018 - 2027F |
6.1.4 United States (US) Organ Preservation Market Revenues & Volume, By Custodial HTK, 2018 - 2027F |
6.1.5 United States (US) Organ Preservation Market Revenues & Volume, By Perfadex, 2018 - 2027F |
6.1.6 United States (US) Organ Preservation Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 United States (US) Organ Preservation Market, By Organ Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Organ Preservation Market Revenues & Volume, By Kidneys, 2018 - 2027F |
6.2.3 United States (US) Organ Preservation Market Revenues & Volume, By Liver, 2018 - 2027F |
6.2.4 United States (US) Organ Preservation Market Revenues & Volume, By Lung, 2018 - 2027F |
6.2.5 United States (US) Organ Preservation Market Revenues & Volume, By Heart, 2018 - 2027F |
6.2.6 United States (US) Organ Preservation Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 United States (US) Organ Preservation Market, By Preservation Technology |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Organ Preservation Market Revenues & Volume, By Static Cold Storage, 2018 - 2027F |
6.3.3 United States (US) Organ Preservation Market Revenues & Volume, By Hypothermic Machine Perfusion, 2018 - 2027F |
6.3.4 United States (US) Organ Preservation Market Revenues & Volume, By Normothermic Machine Perfusion, 2018 - 2027F |
6.3.5 United States (US) Organ Preservation Market Revenues & Volume, By Others, 2018 - 2027F |
7 United States (US) Organ Preservation Market Import-Export Trade Statistics |
7.1 United States (US) Organ Preservation Market Export to Major Countries |
7.2 United States (US) Organ Preservation Market Imports from Major Countries |
8 United States (US) Organ Preservation Market Key Performance Indicators |
9 United States (US) Organ Preservation Market - Opportunity Assessment |
9.1 United States (US) Organ Preservation Market Opportunity Assessment, By Solution, 2021 & 2031F |
9.2 United States (US) Organ Preservation Market Opportunity Assessment, By Organ Type, 2021 & 2031F |
9.3 United States (US) Organ Preservation Market Opportunity Assessment, By Preservation Technology, 2021 & 2031F |
10 United States (US) Organ Preservation Market - Competitive Landscape |
10.1 United States (US) Organ Preservation Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Organ Preservation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |